FDA Warns 15 More Companies on CBD

November 26, 2019 | Eric D. Fader | Cannabis | FDA | Legislation and Public Policy | Pharmaceuticals

On November 25, the U.S. Food and Drug Administration announced the issuance of warning letters to 15 companies that it says are violating the Federal Food, Drug, and Cosmetic Act by selling cannabidiol (CBD) products. The FDA’s views on the recent CBD marketing frenzy have been no secret, as previously discussed here. The FDA also released a revision of the Consumer Update on CBD that it originally published in June.

The warning letters require the companies to respond within 15 working days as to how they will correct the violations. Those that fail to do so may face legal action, including product seizure and/or injunction. It is a safe bet that further warning letters, and perhaps more serious legal action, will be forthcoming.

Share this article:
show more

Get legal updates and news delivered to your inbox